Energy-Based Aesthetic Treatments: What the Evidence Says
Energy-based treatment is a category rather than a treatment, and most of the confusion around it comes from that one fact. Lasers, intense pulsed light, radiofrequency and microfocused ultrasound are grouped together because of how energy is delivered, not because they share a target, a depth, a healing pattern or an evidence base. What is established is narrower than the category suggests: texture, pigment and redness carry the strongest support, tightening is real but weaker and far less predictable, and the claim that a device lifts tissue which has descended is not supported at all. This site separates the claims from the evidence behind them, and reports regulatory approval as the separate question it is.
Chongqing West District Hospital, a tertiary general hospital in Jiulongpo District, Chongqing. This is a review of published evidence and regulation, not medical advice, and it is not a recommendation for or against any treatment.
How claims are graded here
Every claim in this review sits in one of four groups, and the group matters more than the wording. Established means the claim follows from evidence that is consistent across studies and is reflected in how the devices are regulated and labelled — collagen remodelling over months, and improvement in texture, pigment and redness, are in this group. Limited means there is evidence, and it is narrower than the claim usually made from it: tightening sits here, because it can be measured but is modest, slow and variable between people. Emerging means there is a signal and the work is not yet mature, which is where repeated-session and maintenance claims sit. Not supported means the claim is made confidently and the evidence does not carry it, most often because nothing was ever measured for that endpoint at all.
The reason for grading rather than simply reporting is that the four groups are routinely presented as one. A claim that a device remodels collagen for months and a claim that it lifts a descended brow are both made in the same confident register, and only one of them has anything behind it. Where the evidence is thin, this review says so. Where a claim rests on a mechanism rather than on a measurement, it says that too, because the difference between a plausible mechanism and a demonstrated effect is the single most useful distinction a reader can carry into this subject.
What device approval does and does not mean
Approval of an energy device is specific, and it is specific in three directions at once. It belongs to one device, not to a family. It is granted for one indication — pigmented lesions, vascular lesions, hair reduction, wrinkle reduction, tightening — and not for the others. And it is granted per jurisdiction, so a device cleared in one market may be cleared for a narrower set of indications, or not cleared at all, in another. A device can therefore be legitimately approved and carry no approval whatever for the result a person is actually being offered.
Approval is also a different question from whether the treatment works. It is a judgement about whether a device may be marketed for an indication, made on the evidence the regulator was given, and it says nothing about how well the treatment performs in an individual. Every approved device can still produce a burn, a pigment change or a scar; every approved device can fail to produce the change its indication describes. Where a claim rests on approval, this review reports the approval as a fact about regulation and then asks separately what was measured.
Three things follow for a reader. The first is that the label and the cleared indication of a specific device are checkable facts rather than matters of opinion, and they are worth more than the sentence on a clinic page that describes them. The second is that a new indication is not a new mechanism: the same energy at the same depth with a different regulator submission is the same treatment. The third is that the state of regulation changes more slowly than the marketing around it, which is why this review is dated and revisited rather than treated as settled.
What the evidence establishes
These claims survive scrutiny. Each is stated with its own limit rather than as a general reassurance.
Collagen remodelling continues for months
Established, and the reason a result is judged late rather than immediately. Energy delivered into the dermis produces a controlled injury, and the repair that follows continues well after the surface has settled. This is why a photograph taken two weeks after treatment is not evidence of the outcome, and why a plan built on a single early review is built on the wrong moment.
Texture, pigment and redness improve
Established, and the strongest part of the whole category. Lasers and intense pulsed light have a long record against pigmented lesions, vascular lesions and surface irregularity, and the endpoints are the ones the devices are approved for. The limit is that these are surface findings treated at the surface, and the improvement is described in degrees rather than in a guarantee.
Settings and intervals are chosen for a reason
Established as a principle. Depth, fluence and the interval between sessions are selected against the target and the person’s skin, and they are not free variables. This is why a protocol copied from someone else’s treatment is not a protocol, and why changing the settings changes the risk as well as the effect.
Skin type changes the risk profile
Established. The amount of pigment in the skin shapes both what a device can safely target and what happens if it targets the wrong thing, and it is the main reason pigment change after treatment is more likely in some people than others. It is also the reason a plan is assessed on the person rather than on the device alone.
More than one session is often needed
Established for several indications, and it is a statement about how the treatment works rather than about a package. A single pass at a safe setting frequently produces a partial change, and the interval between sessions exists to let the repair finish before the next one begins. What is not established is that a fixed number of sessions suits everyone.
Claims the evidence does not carry
These claims are common, and none of them is supported. Naming them is the most useful thing this review does.
That a device lifts tissue which has descended
Not supported. No energy device is approved to lift a brow, a cheek or a jawline that has descended, and the outcomes that would demonstrate it have not been shown. Where a face has genuinely dropped, the tissue has moved relative to the structures beneath it, and heating it in place does not relocate it. A device may tighten skin around the problem without correcting the problem.
That a higher setting buys a better result
Not supported. Energy and outcome are not in a straight line, and past a point that is specific to the device and the person, more energy buys more injury without buying more result. The settings that produce the best appearance are usually the ones just short of the injury threshold, which is why the same treatment given more aggressively is a different and more dangerous treatment.
That home devices give clinic-grade results
Not supported. Consumer devices are built to a different energy ceiling and a different risk tolerance, and the classes are not interchangeable. A home device may produce a mild change in surface appearance over time; it is not the same intervention as a clinic device, and describing it as though it were is a category error rather than an exaggeration.
That repeated sessions give cumulative improvement without limit
Emerging at best. The reasoning is plausible, and the long-term studies that would establish a cumulative benefit from indefinite repetition do not exist. What does exist is a maintenance claim, which is a marketing category rather than a regulatory one. Repetition also accumulates risk, and that part of the ledger is often left out.
That the category shares one evidence base
Not supported. This is the assumption underneath most device marketing, and it is the one this site exists to correct. A result measured for one family at one depth does not transfer to another family, another indication or another person’s skin. When a page describes a category rather than a device and an indication, it has not yet told you anything checkable.
What the risks are, stated plainly
The first risk is not a device risk at all. It is the risk of choosing a treatment on the strength of a sentence that sounds like evidence, and of deciding about a course of treatment without knowing what the evidence for that device and that indication actually is. That is the risk this site exists to reduce, and it is the one a reader can act on immediately.
The device risks are the ones the evidence and the labelling agree on. A burn is possible, and its severity runs from a superficial injury that settles to a full-thickness injury that scars. Pigment change is possible in both directions, with darkening more likely in some skin types and lightening occasionally permanent. A scar can form, including a raised scar, and an infection can follow a treatment that broke the surface. A blister or a crust that forms after treatment is a sign that the surface was injured more than intended, and it changes what the following weeks look like. None of these is rare enough to be dismissed, and none of them is a reason on its own to avoid treatment; they are the price side of the ledger.
There are limits on the evidence itself, and they belong in a list of risks because they shape what can be claimed. Device studies are frequently small, short and run by people with a commercial interest in the result, and outcomes that depend on judging an appearance are hard to measure in a way that can be compared between studies. Photographic assessment is inconsistently standardised, so the same improvement can appear larger or smaller depending on the light and the angle. Follow-up is often too short to speak to how long a change lasts, which is why durability claims tend to be asserted rather than demonstrated. And a treatment that is safe in a study population is not automatically safe in a person whose skin, medication or history differs from that population.
What else is on the table, including doing nothing
Doing nothing is an option, and for a person with healthy skin and no specific finding it is often the right first one. Skin that is being treated for the sake of a category rather than for a named finding is skin exposed to risk for a benefit that cannot be measured. Where there is a specific finding, the alternatives are usually cheaper, slower and safer than a device, and they are worth knowing before a course of treatment is considered.
Topical treatment is the first alternative for surface findings. A retinoid, used consistently over months, is supported for fine lines and for surface texture, and the evidence for it is longer-running than for most devices. Sun protection is the single best-supported intervention in the whole field and carries almost no downside. Both work slowly, both require continuation, and neither carries the risk of a burn or a scar.
Where the finding is a discrete lesion — a patch of pigment, a group of visible vessels — a device is a reasonable answer and so is treating it once and reviewing, rather than committing to a course. Where the finding is descent of tissue rather than a surface change, the honest alternative is an operation, and a device is not a substitute for it; a surgical assessment answers that question and no energy device does. Where the finding is the appearance of ageing in general, and nothing specific can be named, the alternative is to wait, protect the skin, and revisit the question when something checkable has appeared. Which of these applies is an individual clinical question, and this review does not answer it for anyone.
How this review is kept current
This subject moves on two clocks, and they run at different speeds. The evidence moves slowly, because a well-designed study of a device takes years and the useful endpoints — how long a change lasts, what happens after repeated courses — take longer still. The market moves fast, and it moves by renaming: a device family that has been in use for two decades can reappear under a new name with a new claim and no new evidence, which is why this review is organised around families and indications rather than around product names.
This review is therefore dated and reviewed on a short cycle, and the review covers three things rather than one. The first is whether any claim has moved between the four grading groups, in either direction, because a claim can become supported as well as cease to be. The second is regulatory status, since a new indication, a withdrawn clearance or a changed labelling requirement is a checkable fact that readers are entitled to have current. The third is whether the evidence base has changed in kind: a larger study of the same design is a different event from a study that measures something previously unmeasured, and only the second can settle a question.
Where this review is wrong, the correction is made to the page rather than noted somewhere else, and the date of the most recent review is shown on every page. Where a question is genuinely unresolved, this review states that it is unresolved rather than resolving it by tone. That is a deliberate editorial position: a reader who is told that the answer is not yet known can weigh the uncertainty, and a reader who is given false confidence cannot.
Energy-based treatments: the collagen claim, graded by device family
Every row is a claim you are likely to meet, placed against what the evidence supports and what regulators have actually approved. Evidence and regulatory status are two separate columns because they answer two separate questions.
The evidence guides
Each guide answers one question about the claim rather than about a treatment. Read the two or three that match what you are trying to establish.
What Energy-Based Aesthetic Treatments Actually Are
The families of device, the layer each one reaches, and why energy-based treatment is a category rather than a treatment with a single evidence base.
Read the guide →The Collagen Remodelling Claim: What Is Measured, and When
A process that runs for months is hard to measure and easy to promise. How the collagen remodelling claim is tested and where the evidence behind it is strongest.
Read the guide →Why Energy Devices Keep Arriving Under New Names
The families are few and the labels are many. How to tell a genuinely new device class from a new name on a mechanism that has been in use for years.
Read the guide →Regulatory Status: What Energy Devices Are Approved For
Approval belongs to a device and an indication rather than to a category, and it says nothing about how well a treatment works. What that means for a claim.
Read the guide →What the Evidence Supports Across Energy Device Families
Texture, pigment and redness carry the strongest support. Tightening is weaker, slower and far less predictable, and lifting is not an approved endpoint at all.
Read the guide →What Is Not Established About Energy-Based Treatment
Lifting descended tissue, permanent change, and the assumption that a higher setting buys a better result: three claims the evidence does not carry.
Read the guide →A question about the device evidence?
This site is an evidence review rather than a booking page, and it does not recommend for or against any treatment or offer an assessment in relation to anything it describes. If you have a question about this review, or about what the evidence does and does not cover, contact the team and ask.
Frequently asked questions
What does energy-based aesthetic treatment actually mean?
It describes a delivery method rather than a treatment. Lasers, intense pulsed light, radiofrequency, microfocused ultrasound and fractional resurfacing are grouped together because each puts energy into tissue, not because they share a target, a depth or an evidence base. Questions about whether the category works cannot be answered, because there is no single thing for the answer to be about.
Is tightening with a device established?
It is graded as limited. Tightening can be measured and is real for some people, but it is modest, slow and variable, and it is not the same as lifting. No energy device is approved to lift tissue that has descended, and where a face has genuinely dropped, heating the skin in place does not relocate the tissue beneath it.
Does a stronger setting give a better result?
No. Energy and outcome are not in a straight line, and past a point specific to the device and the person, more energy buys more injury without buying more result. Treatments that produce the best appearance tend to sit just short of the injury threshold, which is why the same treatment delivered more aggressively is a different and more dangerous treatment.
What does device approval cover?
One device, one indication and one jurisdiction. A device can be legitimately approved for pigmented lesions and carry no approval whatever for the tightening a person is being offered. Approval is a judgement about marketing for an indication, and it is a separate question from how well the treatment performs in an individual.
Why does the evidence differ so much between devices?
Because the devices are not the same intervention. Depth, target and healing pattern differ between families, and within a family they differ with the settings. Approval and study evidence exist at the level of the device, the indication and the endpoint, so a good result measured for one of them does not transfer to another.
Can a home device replace a clinic treatment?
No. Consumer devices are built to a different energy ceiling and a different risk tolerance, and the classes are not interchangeable. A home device may produce a mild change in surface appearance over time; it is not the same intervention as a clinic device, and no clinic-grade outcome should be expected from it.
Part of Lasers and Energy Devices — 22 sites on this topic